ERBB2 and non-small cell lung carcinoma: GRP activated HER4 in these NSCLC-cells and stimulated HER4 homodimer/HER2-HER4 heterodimer formation as well as activating ERK and AKT by a reactive-oxygen species (ROS)-dependent mechanism.